Empowering Patient Research

Explore the latest clinical research, patient case studies, and expert videos on intravenous vitamin C — including summaries of peer-reviewed trials, real-world outcomes, and practical safety guidance so you can make an informed decision.

Vitamin C: Functions and Research Overview

WHAT VITAMIN C DOES IN THE BODY
– Vitamin C (ascorbic acid) is a powerful antioxidant that protects cells from free radical damage.
– It donates electrons to neutralize reactive oxygen species (ROS).
– After oxidation, it can be recycled back into active vitamin C using enzymes and glutathione.

ENZYME COFACTOR AND METAL ION REGULATION
– Acts as a cofactor for many enzymes.
– Keeps iron and copper in active forms (Fe3+ → Fe2+ and Cu2+ → Cu+).
– Supports DNA synthesis, epigenetic regulation, and neurotransmitter production.

COLLAGEN AND CONNECTIVE TISSUE HEALTH
– Required for hydroxylation of proline and lysine in collagen synthesis.
– Maintains strong blood vessels, skin, and connective tissues.
– Deficiency leads to weak vessels, poor healing, and scurvy.

OXYGEN SENSING AND CELL METABOLISM
– Required for hydroxylase enzymes regulating HIF‑1 (hypoxia‑inducible factor‑1).
– Controls cell response to low oxygen, glucose metabolism, and angiogenesis.
– Low vitamin C stabilizes HIF‑1, promoting abnormal metabolism and tumor growth.

EPIDEMIOLOGICAL FINDINGS
– Low vitamin C levels linked to higher cancer risk, cardiovascular disease, and mortality.

PRO‑OXIDANT EFFECT AT HIGH DOSES
– At pharmacological levels, vitamin C becomes pro‑oxidant.
– Generates hydrogen peroxide (H2O2) in the presence of iron.
– Causes oxidative stress, DNA damage, and protein oxidation.

SELECTIVE TOXICITY TO CANCER CELLS
– Cancer cells contain more iron and weaker antioxidant systems.
– They cannot detoxify H2O2 efficiently.
– Leads to oxidative damage, autophagy, apoptosis, and necrosis.

IN‑VITRO EVIDENCE
– Sensitive cancer cell lines include pancreatic, cervical, colon, breast, and prostate cancers.
– Chen et al. (2012): 5 of 6 prostate cancer lines sensitive to millimolar ascorbate.
– Cell death mediated by extracellular H2O2.

IN‑VIVO ANIMAL STUDIES
– Oral vitamin C only achieves normal blood levels.
– IV or injection reaches pharmacological levels (~20 mM).
– In mice, high‑dose vitamin C inhibited tumor growth and caused tumor necrosis.

KEY CONCLUSIONS
– Vitamin C is essential for antioxidant defense, collagen synthesis, enzyme activity, iron
metabolism, and gene regulation.
– High‑dose vitamin C selectively damages cancer cells through oxidative stress.
– Effects depend on dose, administration route, and tumor vulnerability.

High-Dose Vitamin C For Cancer Therapy

In recent years, the idea that Vitamin C (Vit-C) could be utilized as a form of anti-cancer therapy has generated many contradictory arguments. Recent insights into the physiological characteristics of Vit-C, its pharmacokinetics, and results from preclinical reports, however, suggest that high-dose Vit-C could be effectively utilized in the management of various tumor types.

View now

Antioxidants And Other Nutrients Do Not Interfere With Chemotherapy Or Radiation Therapy And Can Increase Kill And Increase Survival

Some in the oncology community contend that patients undergoing chemotherapy and/or radiation therapy should not use food supplement antioxidants and other nutrients. Oncologists at an influential oncology institution contended that antioxidants interfere with radiation and some chemotherapies because those modalities kill by generating free radicals that are neutralized by antioxidants, and that folic acid interferes with methotrexate. This is despite the common use of amifostine and dexrazoxane, 2 prescription antioxidants, during chemotherapy and/or radiation therapy.

View now

Doxycycline Inhibits Cancer Stem Cell-Like Properties

Doxycycline inhibits the growth of pancreatic cancer and enhances the treatment effect of 5-fluorouracil (5-FU) in Panc-1 xenograft mouse model. In conclusion, PAR1 promotes the CSC-like properties and EMT of pancreatic cancer cells via the FAK/PI3K/AKT pathway.

View now